SCHEMBL6999375

SCHEMBL6999375

O=C(CN1CCC(c2n[nH]c3c2Cc2ccccc2-3)CC1)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
NPSR1 Q6W5P4 2/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
DRD2 P14416 2/20 0.45
DRD4 P21917 2/20 0.45
DRD3 P35462 2/20 0.45
PDGFRB P09619 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 2/20 0.44
KDM4E B2RXH2 1/20 0.44
THRB P10828 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7000955 0.77 KDR (0.65) LMNASMN1; SMN2
SCHEMBL6999383 0.77 KDR (0.54) ALDH1A1PDGFRBMEN1KMT2ANPC1
SCHEMBL6998835 0.76 KDR (0.53) PDGFRB
SCHEMBL7095976 0.75 CHEK1 (0.55) ALDH1A1LMNASMN1; SMN2NPC1KDM4E
SCHEMBL6996857 0.74 KDR (0.61) PDGFRBLMNASMN1; SMN2
SCHEMBL7092301 0.73 KDR (0.50) PDGFRBNPC1TP53RAB9A
SCHEMBL7001361 0.72 KDR (0.47) PDGFRBMEN1KMT2ATHRB
Hydrochloric Acid SCHEMBL6999499 0.72 KDR (0.46) ALDH1A1PDGFRBKMT2ATHRB
SCHEMBL6893687 0.71 ALDH1A1 (0.79) ALDH1A1NPSR1MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL7092677 0.71 KDR (0.46) ALDH1A1NPSR1PDGFRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed